Section 32 Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 95
  • Portfolio
  • 49
  • Exits
  • 20
Exits

Section 32 General Information

Description

Founded in 2017, Section 32 is a venture capital firm based in Los Altos, California. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, information technology, life sciences, SaaS, cybersecurity, artificial intelligence, machine learning, and technology-based sectors in the United States.

Contact Information

Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 467 1st Street
  • Suite 101
  • Los Altos, CA 94022
  • United States
+1 (650) 000-0000

Section 32 Investments (95)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cohere 15-Feb-2022 Early Stage VC 00000 Business/Productivity Software Generating Revenue
000000000 10-Feb-2022 00000 00000 000.00 Clinics/Outpatient Services Generating Revenue 000000 00000000
000 20-Jan-2022 00000 00000 0000 Discovery Tools (Healthcare) Generating Revenue/Not Profitable
0000000 000 17-Dec-2021 00000 00000 0000 Laboratory Services (Healthcare) Generating Revenue 000000 00000 00.0
0000000 16-Dec-2021 00000 00000 00000 Communication Software Generating Revenue
0000000 16-Dec-2021 00000 00000 0000 Biotechnology Generating Revenue
00000 00000000 15-Dec-2021 00000 00000 0000 Drug Discovery Pre-Clinical Trials
0000 000 09-Dec-2021 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 0000000 0000000 00
Freenome 07-Dec-2021 Later Stage VC 00000 Laboratory Services (Healthcare) Clinical Trials - General
Metaphysic 02-Dec-2021 Early Stage VC 00.000 Multimedia and Design Software Startup 0000 00000
You’re viewing 10 of 95 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Section 32 Exits (20)

Company Name Exit Date Exit Type Exit Size
Dave 04-Jan-2022 Reverse Merger 00000
0000000000 01-Jan-2022 000 00 00000000
0000 17-Dec-2021 0000000 000000 00.00
0000000 000000 23-Nov-2021 000000000000000000 00000
0000000 30-Sep-2021 000000000000000000 00000
000 000000 24-Sep-2021 000 00000
00000000 14-Sep-2021 000000000000000000 00000
00000 22-Jul-2021 0000000 000000 00000
Celularity 16-Jul-2021 Reverse Merger 0000
Singular Genomics 27-May-2021 IPO 00000
You’re viewing 10 of 20 exits. Get the full list »

Section 32 Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Section 32 Team (12)

Name Title Deals Funds Boards Office
Nina Labatt Chief Operating Officer & Chief Financial Officer 0 Los Altos, CA
Jennifer Kercher JD Chief Operating Officer & General Counsel Los Altos, CA
Andrew Harrison Managing Partner 0 0 0 Los Altos, CA
Michael Pellini MD Managing Partner 00 0 00 Los Altos, CA
Steven Kafka Ph.D Managing Partner 0 0 0 Los Altos, CA
You’re viewing 5 of 12 team members. Get the full list »

Section 32 Co-Investors (436)

Name With Exits Lead Partner Series Industry
Casdin Capital 12 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
GV 0 0 0 Series chart Industry bar
Andreessen Horowitz 0 0 0 Series chart Industry bar
You’re viewing 5 of 436 co-investors. Get the full list »